T2 Biosystems Inc
NASDAQ:TTOO
T2 Biosystems Inc
NASDAQ:TTOO
Price:
3.72 USD
1.92%
Market Closed
Updated:
May 4, 2024
T2 Biosystems Inc
Cash from Investing Activities
|
T2 Biosystems Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
T2 Biosystems Inc
NASDAQ:TTOO
|
Cash from Investing Activities
-$192k
|
CAGR 3-Years
83%
|
CAGR 5-Years
20%
|
CAGR 10-Years
8%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is T2 Biosystems Inc's Cash from Investing Activities?
Cash from Investing Activities
-192k
USD
-192k
USD
Based on the financial report for Dec 31, 2023, T2 Biosystems Inc's Cash from Investing Activities amounts to -192k USD.
What is T2 Biosystems Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
8%
8%
The average annual Cash from Investing Activities growth rates for T2 Biosystems Inc have been 83% over the past three years , 20% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
